Global Poultry Healthcare Market Size study & Forecast, by Product Type (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, and Others), Test Type (ELISA-Enzyme-Linked Immunosorbent Assay Test, PCR-Polymerase Chain Reaction Test, Molecular

Global Poultry Healthcare Market Size study & Forecast, by Product Type (Vaccines, Parasiticides, Anti-Infectives, Medical Feed Additives, and Others), Test Type (ELISA-Enzyme-Linked Immunosorbent Assay Test, PCR-Polymerase Chain Reaction Test, Molecular Diagnostic Test, and Other Test Types) and Regional Analysis, 2022-2029

Global Poultry Healthcare Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. Poultry Healthcare refers to the method of treating the animals and other poultry animals. For deriving various animal-based products in the market. The Poultry Healthcare market is expanding because of factors such as rising Occurrence of Zoonotic Diseases and rising demand for Poultry-derived Food and food Products. The market is expected to rise owing to strategic initiatives by the private players in the market and rising healthcare industry. The market is dominated by Elanco, Zoetic Inc, Merck & Co Inc, Hester Biosciences Limited and others.

The need to treat the disorders has increased significantly as well as the number of cases, which is anticipated to fuel market growth during the forecast period. For instance, the 2022 figures released by the Government of Canada show that as of June 2022, it was anticipated that 963,889 birds in Alberta will be affected by avian influenza in 2022, followed by 560,536 birds in Ontario and 300,835 birds in Quebec. Further, according to a November 2021 paper titled ""Prevalence of Newcastle Disease Virus in Industrial and Backyard Poultry in Haryana, India,"" a stratified research study was carried out from March 2018 to March 2020. Using the M gene rRT-PCR, it was revealed that both commercial broilers and layers tested positively for Newcastle disease virus (NDV). According to the same source, flocks with mild respiratory problems showed a higher prevalence of Newcastle disease virus (15.7%), followed by healthy (9.1%) and sick (3.0%) flocks. However, use of counterfeit medicines, lack of veterinarians in the market and shortage of skilled farm workers may halt market growth.

The key regions considered for the Global Poultry Healthcare Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the space in terms of revenue, rising demand for poultry-derived food products. According to Nass.usda.gov, Broilers produced in 2020 were valued at USD 21.7 billion, a 23% decrease from 2019. In 2020, 9.22 billion broilers were generated in total, an increase from 2019. In 2020, 59.4 billion pounds of live weight broilers were generated, an increase of 2% from 2019. Asia Pacific is expected to grow significantly during the forecast period, owing to rising

Major market player included in this report are:
Indovax
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Ceva Sante Animale
Merck & Co Inc
IDEXX Laboratories, Inc.
Megacor Diagnostik GmbH
Elanco
Zoetis Inc.
Hester Biosciences Limited

Recent Developments in the Market:
 In May 2022, Canada invested approximately USD 3 million, in the development of the livestock and poultry industries.. The main objective of this country is to enhance the disaster management and develop risk assessments for mitigating the disease occurrences. Further, this project will enhance the emergency management abilities of Canada's livestock and poultry industries, in the long run.
 In April 2022, Ceva Animal Health launched CEVAC IBird. IBird is a live assuaged freeze-dried vaccine which is specifically used for the active inoculation of chickens that are used against the variant strain of avian contagious bronchitis virus which is containing strain 1/96, in India.

Global Poultry Healthcare Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Test Type and Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:
By Product type:
Vaccines
Parasiticides
Anti-Infectives
Medical Feed Additives
Others

By Test Type:
Elisa Test
PCR Test
Molecular Diagnostic Test
Other Test Types

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Companies Mentioned

Indovax
Thermo Fisher Scientific Inc.
Boehringer Ingelheim GmbH
Ceva Sante Animale
Merck & Co Inc
IDEXX Laboratories, Inc.
Megacor Diagnostik GmbH
Elanco
Zoetis Inc.
Hester Biosciences Limited

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.